This is a biased opinion as I truly believe the Psychedelic stock market will be expanding more and more in the years to come.
Hence my long term bullish approach.
Mindmed has been in a downtrend since Q3 21.
Early February, price was rejected at yearly open. I do not think this reflects the company value but rather a market sentiment.
Earnings early march might...
